Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials and causation: Bayesian perspectives

K F Schaffner1

  • 1George Washington University, Washington, DC 20052.

Statistics in Medicine
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organizational mediators of sustainability in a randomized controlled trial.

Evidence-based practice in child and adolescent mental health·2025
Same author

Biopsychosocial foundations.

The American journal of bioethics : AJOB·2002
Same author

Preventing severe mental illnesses--new prospects and ethical challenges.

Schizophrenia research·2001
Same author

Medical informatics and the concept of disease.

Theoretical medicine and bioethics·2000
Same author

Coming home to Hume: a sociobiological foundation for a concept of 'health' and morality.

The Journal of medicine and philosophy·1999
Same author

Paradigm changes in organ transplantation: a journey toward selflessness?

Theoretical medicine and bioethics·1999
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Establishing causal efficacy of treatments requires clear causation concepts. This study examines clinical trial causation, contrasting manipulability and epidemiological approaches, and their links to complex causality frameworks.

Area of Science:

  • Philosophy of Science
  • Epidemiology
  • Biostatistics
  • Clinical Trials

Background:

  • Clinical trials are considered the gold standard for establishing treatment efficacy and safety.
  • The underlying concept of causation in clinical trials is often assumed to be straightforward but warrants deeper examination.
  • Existing statistical and regulatory views on causation in clinical trials may overlook crucial nuances.

Purpose of the Study:

  • To critically evaluate the concept of causation as applied in clinical trials.
  • To compare and contrast the manipulability approach to causation with epidemiological causation.
  • To explore the connections between these causal concepts and advanced frameworks like directed graphical causal modeling.

Main Methods:

Related Experiment Videos

  • Discussion of the manipulability (counterfactual) approach to causation.
  • Characterization of 'epidemiological causation' as probabilistic and population-level.
  • Analysis of relationships between different causal concepts and frameworks (Cartwright, Rubin, Holland, Glymour).

Main Results:

  • The concept of causation in clinical trials is not as clear as commonly assumed.
  • The manipulability approach, while useful in physiology, has unclear links to population-level epidemiological causation.
  • Epidemiological causation is probabilistic, population-dependent, and relies on specific criteria and study designs.

Conclusions:

  • A clearer understanding of causation is essential for interpreting clinical trial results accurately.
  • Integrating different perspectives on causation can enhance the rigor of epidemiological and clinical research.
  • Further clarification is needed to bridge the gap between individual-level and population-level causal inference.